Rigaku recommends the following systems: 
Molecular structure determination
XtaLAB mini II   Chemical crystallography
Determine the molecular structure of small molecules
  XtaLAB Synergy-S   Protein crystallography
Determine the molecular structure of macro molecules
Phase, elemental and chemical i.d. data for quality control
Supermini   Elemental analysis
With EDXRF and WDXRF products
  MiniFlex   Phase analysis
From benchtop to mainframe XRD products
  Progeny   Chemical i.d.
With portable and handheld RAMAN systems
Small Angle Scattering for R&D and formulation optimization
Small and wide angle X-ray scattering instrument designed for nano-structure analyses
  NANOPIX mini  

The world’s first benchtop small angle X-ray scattering (SAXS) system

  NanoMAX   NanoMAX
A modernized 2D Kratky system that eliminates data corrections required of traditional systems

From molecular structure to quality assurance


In medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are discovered and designed. In the recent past, most drugs have been discovered either by identifying the active ingredient from traditional remedies or by serendipitous discovery. A new approach, using so-called "rational drug design", has been to understand how disease and infection are controlled at the molecular and physiological level and to target specific entities based on this knowledge. Given this importance, Rigaku has been at the forefront in the development of single crystal diffraction for both macromolecular and small molecule structure determination. Rigaku products range from automated crystallization and crystal imaging through crystal diffraction screening and high-resolution data collection systems to 3D structure refinement and imaging software.

X-ray powder diffraction is extensively used in the drug discovery, design, development and formulation processes to obtain critical knowledge about pharmaceutical products. Many parameters required by the FDA, legal patent issues and drug performance are only accessible by employing XRD. With the introduction of systems specifically developed with the pharmaceutical industry in mind, XRD is now both cost-effective and easy-to-use. Phase analysis and polymorph identification are common analytical needs within both pharmaceutical development and production. In addition, crystal structure determination, the study of non-ambient behavior, and overall morphology help to provide a complete understanding of the properties of a pharmaceutical agent.